Safety Study of Allogeneic Mesenchymal Precursor Cell Infusion in Myocardial Infarction

NCT01781390 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myocardial Infarction

Interventions

OTHER: Placebo
BIOLOGICAL: Mesenchymal Precursor Cells (MPC) 12.5 M
BIOLOGICAL: Mesenchymal Precursor Cells (MPC) 25 M

Sponsor

Mesoblast, Inc.